SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
REDUCTION IN INFECTIOUS SARS-COV-2 IN TREATMENT STUDY OF COVID-19 WITH MOLNUPIRAVIR
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
REDUCTION IN INFECTIOUS SARS-COV-2 IN TREATMENT STUDY OF COVID-19 WITH MOLNUPIRAVIR (ABSTRACT
777)
Wendy P Painter
Ridgeback Biotherapeutics LP, Miami, FL, USA
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
